Wellumio
Brief
Wellumio is a New Zealand medical device company developing portable neuroimaging technology to improve the speed and accuracy of acute stroke diagnosis.
Profile
Its flagship product, Axana®, uses the company's proprietary Pulsed Gradient Free Mapping (PGFM) method to identify brain tissue affected by stroke, enabling rapid, point-of-care assessment in acute care settings.
By addressing the limitations of traditional MRI systems, Wellumio aims to support earlier clinical decision-making and improve outcomes for stroke patients worldwide.
Headquarters
